Public sector innovation and the constraints of ‘platform thinking’: An account of Johnson & Johnson's adenoviral vector vaccines
Scientists must recognize platform thinking to prevent it from unduly shaping the trajectory of biomedical research. Political and scientific leaders should invest in public-sector capacity so that promising technologies can be brought to the public without need for an industry partner in every instance.
Authors
- Christopher J. Morten
- Matthew Herder (ORCID: https://orcid.org/0000-0001-5319-6199)
- Karim Sariahmed (ORCID: https://orcid.org/0000-0002-1522-5267)
- Janice Graham (ORCID: https://orcid.org/0000-0002-6326-8122)
Institutions
- Boston University (US)
- Dalhousie University (CA)
- New York Law School (US)
- New York University (US)
Publication Details
- Journal
- Social Science & Medicine
- Published
- 2025-10-17
- DOI
- https://doi.org/10.1016/j.socscimed.2025.118687
- Primary Topic
- Innovation and Socioeconomic Development
- Type
- article
- Field-Weighted Citation Impact
- 0.00